An exploratory analysis of ctDNA extracted from patients with PDGFRA D842V-mutant GIST enrolled in the phase 1 study of avapritinib was presented at the European Society of Medical Oncology annual meeting in 2018. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.